Applied Therapeutics Provides Regulatory Update on Galactosemia Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500, Dow rise on Mideast deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Applied Therapeutics Inc. (APLT) Declines 50% After Shares Resume Trading
January 3, 2022 7:32 AM ESTApplied Therapeutics Inc. (NASDAQ: APLT) Declines 50% After Shares Resume Trading
... MoreApplied Therapeutics Inc. (APLT) to Resume Trading at 7:30 a.m.
January 3, 2022 7:05 AM ESTApplied Therapeutics Inc. (NASDAQ: APLT) to Resume Trading at 7:30 a.m.
... More